For example, loading doxorubicin into MSC-EVs facilitates osteosarcoma therapy, with doxorubicin-loaded MSC-EVs targeting osteosarcoma therapy via the SDF1-CXCR4 axis [90, 113]. The gene discussed is CXCR4; the disease is osteosarcoma.